V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208341 | 20077781 | 1.55 | 102.7 | null | 2018-10-02 | 2018-10-10 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100286871 |
| 20208343 | 20077782 | 1.82 | 68 | Palliative (P) | 2019-12-23 | 2019-12-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100757282 |
| 20208345 | 20077783 | 0 | 0 | Palliative (P) | 2016-06-27 | 2016-07-18 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100190210 |
| 20208352 | 20077784 | null | 80.85 | Neo-adjuvant (N) | 2019-04-04 | 2019-05-31 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101439326 |
| 20208355 | 20077785 | 1.75 | 92.7 | Curative (C) | 2018-10-09 | 2018-10-09 | CISPLATIN + FLUOROURACIL + RT | null | N | CISPLATIN + FLUOROURACIL | 100330613 |
| 20208358 | 20077786 | 1.65 | 73 | Adjuvant (A) | 2018-01-07 | 2018-01-08 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101846150 |
| 20208362 | 20077787 | 1.69 | 584 | null | 2017-12-17 | 2017-12-27 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100818432 |
| 20208364 | 20077788 | 1.68 | 83 | Neo-adjuvant (N) | 2019-02-10 | 2019-02-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100311470 |
| 20208367 | 20077789 | 1.72 | 43.5 | null | 2018-01-06 | 2018-01-09 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100424301 |
| 20208368 | 20077790 | 1.62 | 67.9 | Neo-adjuvant (N) | 2018-10-12 | 2018-10-27 | Capecitabine (21days) + Carboplatin | 2 | N | CISPLATIN + FLUOROURACIL | 101526462 |
| 20208371 | 20077791 | 1.57 | 0 | Neo-adjuvant (N) | 2016-09-28 | 2016-10-12 | Cisplatin +Fluorouracil (3 wk) | null | N | CISPLATIN + FLUOROURACIL | 101738683 |
| 20208372 | 20077792 | null | 47 | null | 2018-09-06 | 2018-09-06 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 100291324 |
| 20208378 | 20077793 | 1.56 | 51.3 | Neo-adjuvant (N) | 2017-07-07 | 2017-11-20 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101793037 |
| 20208388 | 20077794 | null | null | Palliative (P) | 2020-01-28 | 2020-02-23 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101196792 |
| 20208390 | 20077795 | 1.7 | 80 | Curative (C) | 2017-08-07 | 2017-08-10 | CAPECITABINE + CARBOPLATIN | 02 | Y | TRIAL UNSPECIFIED | 101193925 |
| 20208400 | 20077796 | 1.66 | 66 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100098123 |
| 20208402 | 20077797 | 1.78 | 42.5 | null | 2017-08-13 | 2017-09-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101174405 |
| 20208404 | 20077798 | 1.53 | 44 | 03 | 2020-11-06 | 2020-11-11 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100445596 |
| 20208412 | 20077799 | 1.73 | 62.7 | Curative (C) | 2020-01-14 | 2020-01-18 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 100908900 |
| 20208425 | 20077800 | 1.67 | 93 | Palliative (P) | 2018-03-24 | 2018-04-07 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100388479 |
| 20208426 | 20077801 | 1.78 | 44.65 | Palliative (P) | 2017-11-25 | 2017-12-03 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100389360 |
| 20208431 | 20077802 | 1.67 | 60 | Curative (C) | 2019-01-06 | 2019-01-06 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101191150 |
| 20208433 | 20077803 | null | 102 | Palliative (P) | 2017-01-29 | 2017-02-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101262325 |
| 20208434 | 20077804 | 1.68 | 67.8 | Curative (C) | 2018-05-19 | 2018-05-19 | Cisplatin +Fluorouracil (3 wk) | 2 | N | CISPLATIN + FLUOROURACIL | 100021945 |
| 20208436 | 20077805 | 1.91 | 63.3 | Curative (C) | 2018-05-29 | 2018-06-14 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101703713 |
| 20208440 | 20077806 | null | 69.5 | Palliative (P) | 2016-08-11 | 2016-08-12 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100338179 |
| 20208450 | 20077807 | 1.82 | 62.8 | Palliative (P) | 2019-12-27 | 2020-01-25 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101828578 |
| 20208453 | 20077808 | 1.72 | 55 | Palliative (P) | 2018-11-13 | 2018-12-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100391648 |
| 20208456 | 20077809 | 0 | 0 | 03 | 2020-02-25 | 2020-03-21 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100291884 |
| 20208459 | 20077810 | 1.6 | null | Palliative (P) | 2018-11-29 | 2018-12-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101848345 |
| 20208474 | 20077811 | 1.7 | 86.2 | null | 2018-12-17 | 2018-12-18 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100415616 |
| 20208477 | 20077812 | 0 | 0 | Palliative (P) | 2017-10-08 | 2017-11-22 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100202321 |
| 20208501 | 20077813 | 1.52 | 74.75 | Curative (C) | 2017-07-19 | 2017-07-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101333452 |
| 20208507 | 20077814 | 1.74 | 78 | Palliative (P) | 2016-04-09 | 2016-04-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101273033 |
| 20208511 | 20077815 | 1.76 | 71.5 | null | null | 2018-06-17 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101452543 |
| 20208521 | 20077816 | 1.62 | 54.4 | Palliative (P) | 2019-07-17 | 2019-08-05 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100322471 |
| 20208526 | 20077817 | 1.62 | 79.2 | Palliative (P) | 2018-03-12 | 2018-03-14 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101348166 |
| 20208530 | 20077818 | 1.82 | 56.3 | Palliative (P) | 2018-09-18 | 2018-10-09 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100836885 |
| 20208531 | 20077819 | null | null | Curative (C) | 2018-04-03 | 2018-04-09 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100840809 |
| 20208534 | 20077820 | 1.7 | 69.6 | Palliative (P) | 2018-02-17 | 2018-03-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101132400 |
| 20208540 | 20077821 | 1.81 | 85 | Neo-adjuvant (N) | 2017-08-13 | 2017-08-21 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100345520 |
| 20208541 | 20077822 | 1.7 | 73.1 | Palliative (P) | null | 2016-11-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100030475 |
| 20208542 | 20077823 | 1.83 | null | Neo-adjuvant (N) | 2019-09-15 | 2019-09-15 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101017096 |
| 20208546 | 20077824 | 1.59 | 182 | Curative (C) | 2019-02-19 | 2019-03-20 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100854432 |
| 20208548 | 20077825 | 1.53 | 90.5 | Palliative (P) | 2019-06-09 | 2019-06-15 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 100810252 |
| 20208550 | 20077826 | 1.79 | 60.3 | Palliative (P) | 2018-11-30 | 2018-11-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101091027 |
| 20208551 | 20077827 | 1.75 | 76.8 | null | 2019-05-10 | 2019-05-15 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100906951 |
| 20208553 | 20077828 | 1.72 | 84.2 | Curative (C) | 2017-03-10 | 2017-04-04 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100972946 |
| 20208556 | 20077829 | 1.84 | 65.4 | Neo-adjuvant (N) | 2016-12-30 | 2016-12-31 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100509040 |
| 20208558 | 20077830 | 1.72 | 85.5 | Palliative (P) | 2019-10-03 | 2019-10-11 | Cisplatin + Fluorouracil + RT 5day | null | N | CISPLATIN + FLUOROURACIL | 100937956 |